These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 15248850

  • 1. Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure.
    von Bubnoff D, Fimmers R, Bogdanow M, Matz H, Koch S, Bieber T.
    Clin Exp Allergy; 2004 Jul; 34(7):1056-63. PubMed ID: 15248850
    [Abstract] [Full Text] [Related]

  • 2. Indoleamine 2,3-dioxygenase (IDO) activity is lower in atopic than in non-atopic individuals and is enhanced by environmental factors protecting from atopy.
    Raitala A, Karjalainen J, Oja SS, Kosunen TU, Hurme M.
    Mol Immunol; 2006 Mar; 43(7):1054-6. PubMed ID: 15992929
    [Abstract] [Full Text] [Related]

  • 3. Recurrent headache as the main symptom of acquired cerebral toxoplasmosis in nonhuman immunodeficiency virus-infected subjects with no lymphadenopathy: the parasite may be responsible for the neurogenic inflammation postulated as a cause of different types of headaches.
    Prandota J.
    Am J Ther; 2007 Mar; 14(1):63-105. PubMed ID: 17303977
    [Abstract] [Full Text] [Related]

  • 4. Are indoleamine-2,3-dioxygenase producing human dendritic cells a tool for suppression of allogeneic T-cell responses?
    Löb S, Ebner S, Wagner S, Weinreich J, Schäfer R, Königsrainer A.
    Transplantation; 2007 Feb 27; 83(4):468-73. PubMed ID: 17318080
    [Abstract] [Full Text] [Related]

  • 5. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season.
    Grindebacke H, Wing K, Andersson AC, Suri-Payer E, Rak S, Rudin A.
    Clin Exp Allergy; 2004 Sep 27; 34(9):1364-72. PubMed ID: 15347368
    [Abstract] [Full Text] [Related]

  • 6. Enhanced indoleamine 2,3-dioxygenase activity in patients with severe sepsis and septic shock.
    Tattevin P, Monnier D, Tribut O, Dulong J, Bescher N, Mourcin F, Uhel F, Le Tulzo Y, Tarte K.
    J Infect Dis; 2010 Mar 15; 201(6):956-66. PubMed ID: 20151841
    [Abstract] [Full Text] [Related]

  • 7. Indoleamine 2,3-dioxygenase in lung allograft tolerance.
    Meloni F, Giuliano S, Solari N, Draghi P, Miserere S, Bardoni AM, Salvini R, Bini F, Fietta AM.
    J Heart Lung Transplant; 2009 Nov 15; 28(11):1185-92. PubMed ID: 19783182
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma.
    Liebau C, Baltzer AW, Schmidt S, Roesel C, Karreman C, Prisack JB, Bojar H, Merk H.
    Anticancer Res; 2002 Nov 15; 22(2A):931-6. PubMed ID: 12014674
    [Abstract] [Full Text] [Related]

  • 9. Depletion of CD4+CD25+CD127lo regulatory T cells does not increase allergen-driven T cell activation.
    Skrindo I, Farkas L, Kvale EO, Johansen FE, Jahnsen FL.
    Clin Exp Allergy; 2008 Nov 15; 38(11):1752-9. PubMed ID: 18681851
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase.
    Funeshima N, Fujino M, Kitazawa Y, Hara Y, Hara Y, Hayakawa K, Okuyama T, Kimura H, Li XK.
    J Gene Med; 2005 May 15; 7(5):565-75. PubMed ID: 15543532
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Indoleamine 2,3-dioxygenase-dependent tryptophan metabolites contribute to tolerance induction during allergen immunotherapy in a mouse model.
    Taher YA, Piavaux BJ, Gras R, van Esch BC, Hofman GA, Bloksma N, Henricks PA, van Oosterhout AJ.
    J Allergy Clin Immunol; 2008 Apr 15; 121(4):983-91.e2. PubMed ID: 18179817
    [Abstract] [Full Text] [Related]

  • 13. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
    Schefold JC, Zeden JP, Fotopoulou C, von Haehling S, Pschowski R, Hasper D, Volk HD, Schuett C, Reinke P.
    Nephrol Dial Transplant; 2009 Jun 15; 24(6):1901-8. PubMed ID: 19155537
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Helicobacter pylori-induced indoleamine 2,3-dioxygenase activity in vivo is regulated by TGFB1 and CTLA4 polymorphisms.
    Raitala A, Karjalainen J, Oja SS, Kosunen TU, Hurme M.
    Mol Immunol; 2007 Feb 15; 44(5):1011-4. PubMed ID: 16620985
    [Abstract] [Full Text] [Related]

  • 16. Tryptophan degradation in patients with gynecological cancer correlates with immune activation.
    Schroecksnadel K, Winkler C, Fuith LC, Fuchs D.
    Cancer Lett; 2005 Jun 08; 223(2):323-9. PubMed ID: 15896467
    [Abstract] [Full Text] [Related]

  • 17. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.
    Le Rond S, Gonzalez A, Gonzalez AS, Carosella ED, Rouas-Freiss N.
    Immunology; 2005 Nov 08; 116(3):297-307. PubMed ID: 16236119
    [Abstract] [Full Text] [Related]

  • 18. Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season.
    Pertovaara M, Hasan T, Raitala A, Oja SS, Yli-Kerttula U, Korpela M, Hurme M.
    Clin Exp Immunol; 2007 Nov 08; 150(2):274-8. PubMed ID: 17711489
    [Abstract] [Full Text] [Related]

  • 19. Indoleamine 2,3-dioxygenase is highly expressed in human adult T-cell leukemia/lymphoma and chemotherapy changes tryptophan catabolism in serum and reduced activity.
    Hoshi M, Ito H, Fujigaki H, Takemura M, Takahashi T, Tomita E, Ohyama M, Tanaka R, Saito K, Seishima M.
    Leuk Res; 2009 Jan 08; 33(1):39-45. PubMed ID: 18639341
    [Abstract] [Full Text] [Related]

  • 20. Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality.
    Pertovaara M, Raitala A, Lehtimäki T, Karhunen PJ, Oja SS, Jylhä M, Hervonen A, Hurme M.
    Mech Ageing Dev; 2006 May 08; 127(5):497-9. PubMed ID: 16513157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.